Public Company

Aurobindo Pharma receives Swissmedic approval for cefepime for injection

Hyderabad-based Aurobindo Pharma Limited received approval from Swissmedic, an agency of Switzerland government for therapeutic products, for the licence of Cefepime APL for injection 1g and 2g. - Ranbaxy receives final USFDA approval for Glycopyrolate - SC pulls up Ranbaxy for delayed raising of refund issue - Sun Pharma invalidates Eli Lilly"s Gemzar patent - Glenmark"s drug fails clinical trials - Aurobindo Pharma up 2.4% - Aurobindo to acquire Trident Life This is used for moderate to severe pneumonia, septicaemia, skin and intra-abdominal infections. This is Auorbindo"s second product approval from Swissmedic, according to a press release. The company scrip was trading at Rs 730 on BSE, down 0.35 per cent compared to the previous day"s close of Rs 715.5.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
CES aims turnover of Rs 350 cr in 2009-10
Leading engineering consultant, Consulting Engineering Services (India) Private Ltd (CES) looks for a total turnover of Rs 350 crore in 2009-10 by providing designing and consultancy services in several key infrastructure projects in the domestic and overseas markets.
Popular Articles

Global tie-ups, private labels to be buzzwords in retail this year
Tie-ups with international retailers and brands, emphasis on profitable growth and increased focus on private labels are set to be key trends in the Indian retail sector in 2010, say retailers and consultants Business Standard spoke to.

Advance tax kitty rises 20% during Apr-Dec
The advance tax collection from India Inc rose 20 per cent during the first nine months of the current fiscal compared to the same period last year, with automobiles, consumer goods and metals leading the pack.

© Copyright 2009